Page Banner

United States Department of Agriculture

Agricultural Research Service

Research Project: COUNTERMEASURES TO CONTROL FOREIGN ANIMAL DISEASES OF SWINE

Location: Foreign Animal Disease Research

Title: Effects of glycosylation on antigenicity and immunogenicity of classical swine fever virus envelope proteins

Authors
item Gavrilov, Boris -
item Rogers, Kara -
item Fernandez Sainz, Ignacio
item Holinka, Lauren
item Borca, Manuel
item Risatti, Guillermo -

Submitted to: Virology
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: August 31, 2011
Publication Date: October 2, 2011
Repository URL: http://handle.nal.usda.gov/10113/54311
Citation: Gavrilov, B.K., Rogers, K., Fernandez Sainz, I.J., Holinka-Patterson, L.G., Borca, M.V., Risatti, G.R. 2011. Effects of glycosylation on antigenicity and immunogenicity of classical swine fever virus envelope proteins. Virology. 420:135-145.

Interpretive Summary: Classical swine fever virus (CSFV) has three glycoproteins (proteins with a high content of sugars in their molecules) in its external membrane (E(rns), E1 and E2). Here we analyzed the effects of lack of sugar in the immunogenicity of E(rns), E1, and E2 proteins. All three proteins lacking glycosylation, failed to induce a detectable virus neutralizing antibody response and protection against CSFV. In addition, it was observed that single administration of purified E(rns) glycoprotein induced an effective protection against CSFV infection.

Technical Abstract: Classical swine fever virus (CSFV) harbors three envelope glycoproteins (E(rns), E1 and E2). Previous studies have demonstrated that removal of specific glycosylation sites within these proteins yielded attenuated and immunogenic CSFV mutants. Here we analyzed the effects of lack of glycosylation of baculovirus-expressed E(rns), E1, and E2 proteins on immunogenicity. Interestingly, E(rns), E1, and E2 proteins lacking proper post-translational modifications, most noticeable lack of glycosylation, failed to induce a detectable virus neutralizing antibody (NA) response and protection against CSFV. Similarly, no NA or protection was observed in pigs immunized with E1 glycoprotein. Analysis of E(rns) and E2 proteins with single site glycosylation mutations revealed that detectable antibody responses, but not protection against lethal CSFV challenge is affected by removal of specific glycosylation sites. In addition, it was observed that single administration of purified E(rns) glycoprotein induced an effective protection against CSFV infection.

Last Modified: 9/1/2014
Footer Content Back to Top of Page